Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

ELOVL1 anticorps (AA 82-175)

ELOVL1 Reactivité: Humain ELISA, IHC, IF Hôte: Lapin Polyclonal unconjugated
N° du produit ABIN7151556
  • Antigène Voir toutes ELOVL1 Anticorps
    ELOVL1 (ELOVL Fatty Acid Elongase 1 (ELOVL1))
    Épitope
    • 14
    • 9
    • 5
    • 4
    • 2
    • 1
    • 1
    • 1
    • 1
    AA 82-175
    Reactivité
    • 39
    • 16
    • 4
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    Humain
    Hôte
    • 39
    Lapin
    Clonalité
    • 39
    Polyclonal
    Conjugué
    • 16
    • 5
    • 5
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Cet anticorp ELOVL1 est non-conjugé
    Application
    • 27
    • 25
    • 5
    • 3
    • 2
    • 2
    ELISA, Immunohistochemistry (IHC), Immunofluorescence (IF)
     Réactivité croisée
    Humain
    Purification
    >95%, Protein G purified
    Immunogène
    Recombinant Human Elongation of very long chain fatty acids protein 1 protein (82-175AA)
    Isotype
    IgG
  • Indications d'application
    Recommended dilution: IHC:1:20-1:200, IF:1:50-1:200,
    Restrictions
    For Research Use only
  • Format
    Liquid
    Buffer
    Preservative: 0.03 % Proclin 300
    Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4
    Agent conservateur
    ProClin
    Précaution d'utilisation
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
  • Antigène
    ELOVL1 (ELOVL Fatty Acid Elongase 1 (ELOVL1))
    Autre désignation
    ELOVL1 (ELOVL1 Produits)
    Synonymes
    anticorps AA407424, anticorps BB151133, anticorps Ssc1, anticorps elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 1, anticorps ELOVL fatty acid elongase 1, anticorps Elovl1, anticorps ELOVL1
    Sujet

    Background: Catalyzes the first and rate-limiting reaction of the four that constitute the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process, allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids/VLCFAs per cycle. Condensing enzyme that exhibits activity toward saturated C18 to C26 acyl-CoA substrates, with the highest activity towards C22:0 acyl-CoA. May participate to the production of both saturated and monounsaturated VLCFAs of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators. Important for saturated C24:0 and monounsaturated C24:1 sphingolipid synthesis. Indirectly inhibits RPE65 via production of VLCFAs.

    Aliases: 3 keto acyl CoA synthase ELOVL1 antibody, 3-keto acyl-CoA synthase ELOVL1 antibody, CGI 88 antibody, Elongation of very long chain fatty acids (FEN1/Elo2 SUR4/Elo3 yeast) like 1 antibody, Elongation of very long chain fatty acids like 1 antibody, Elongation of very long chain fatty acids protein 1 antibody, ELOV1_HUMAN antibody, ELOVL 1 antibody, ELOVL FA elongase 1 antibody, ELOVL fatty acid elongase 1 antibody, ELOVL1 antibody, Ssc1 antibody, Ssc1, mouse, homolog of antibody, very long chain 3 oxoacyl CoA synthase 1 antibody, Very-long-chain 3-oxoacyl-CoA synthase 1 antibody

    UniProt
    Q9BW60
Vous êtes ici:
Support technique